Quebec becomes the first province to publicly reimburse Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anemia

GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l'assurance maladie du Québec ...

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

According to Diabète Québec, type 2 diabetes is the most common form, affecting nearly 90% of those living with diabetes, and many eventually require insulin when lifestyle changes and oral ...

Teva Canada Welcomes RAMQ Reimbursement Update Supporting Access to ADHD Treatments

Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement ...
JSTOR Daily

Assurance maladie : la gestion du risque long / Long term health risk and insurance

Cet article étudie les enjeux spécifiques à l'assurance de long terme, dans le cas particulier de l'assurance contre le risque maladie. Spécifiquement, deux éléments essentiels du risque long sont ...
Financial Post

Slynd® (drospirenone) is now covered by the Régie de l'assurance maladie du Québec

BLAINVILLE, Quebec, July 12, 2023 (GLOBE NEWSWIRE) — Duchesnay Inc., a pharmaceutical company specializing in women’s health and member of Duchesnay Pharmaceutical Group headquartered in Blainville, ...
Morningstar

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. Dexcom, ...